HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.656
+0.016 (0.61%)
At close: Mar 9, 2026, 4:00 PM EDT
2.870
+0.214 (8.06%)
After-hours: Mar 9, 2026, 7:40 PM EDT

HeartSciences Revenue

HeartSciences had revenue of $2.42K in the quarter ending October 31, 2025. This brings the company's revenue in the last twelve months to $8.67K, down -41.03% year-over-year. In the fiscal year ending April 30, 2025, HeartSciences had annual revenue of $4.35K, down -76.61%.

Revenue (ttm)
$8.67K
Revenue Growth
-41.03%
P/S Ratio
974.29
Revenue / Employee
$578
Employees
15
Market Cap
8.45M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 20254.35K-14.25K-76.61%
Apr 30, 202418.60K13.45K261.17%
Apr 30, 20235.15K-9.22K-64.17%
Apr 30, 202214.37K-11.23K-43.86%
Apr 30, 202125.60K-38.58K-60.11%
Apr 30, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Trinity Biotech 48.57M
Lifeward 24.50M
INVO Fertility 6.94M
Beyond Air 6.92M
Biomerica 4.46M
Intelligent Bio Solutions 3.58M
Tenon Medical 3.23M
Sintx Technologies 1.27M
Revenue Rankings